CardioExchange Archive

November 19th, 2012

Selections from Richard Lehman’s Literature Review: November 19th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include multivitamins and cancer prevention in men, a comparison of atorvastatin with or without a PCSK9 Antibody in primary hypercholesterolemia, type-2 diabetes screening and population mortality over 10 years, and more.

---

October 29th, 2012

Selections from Richard Lehman’s Literature Review: October 29th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include CV risk factors and peripheral artery disease in men, radiofrequency ablation in paroxysmal AF, CPR duration and survival after in-hospital cardiac arrest, an everolimus-eluting stent vs. a bare-metal stent in STEMI, job strain and CHD, and more.

---

September 24th, 2012

Stress and Coronary Heart Disease: What Role Does Gender Play?

Xiao Xu, PhD

Xiao Xu examines the unique stressors – both at home and at work – that women and men may face.

---

July 26th, 2012

ESC Position Paper: Population-Based Strategies to Reduce CV Deaths

Larry Husten, PHD

About half of all cardiovascular deaths could be prevented by implementing population-level changes, according to a position paper from the European Society of Cardiology published in the European Journal of Preventive Cardiology. Torben Jørgensen and colleagues maintain that population-level interventions are much more effective than current strategies that seek to reduce individual risk. Population-based strategies include taxation, legislation, and […]

---

June 28th, 2012

What Reading That “Low-Carb Gives You Heart Disease” Paper Actually Told Me

Yoni Freedhoff, MD

A BMJ paper that concludes a low-carb diet can increase CV risk in women draws harsh words from Yoni Freedhoff.

---

May 21st, 2012

Selections from Richard Lehman’s Literature Review: Week of May 21st

Richard Lehman, BM, BCh, MRCGP

This week’s topics include warfarin vs. aspirin for stroke prevention in HF, CVD risks and azithromycin, coffee’s benefits, the old news that statins work, the question of HDL-C, abdominal aortic aneurysm, omega-3 fatty acid supplements, and Abbott’s methods for staying ahead with fenofibrate prescriptions.

---

May 14th, 2012

Selections from Richard Lehman’s Literature Review: Week of May 14th

Richard Lehman, BM, BCh, MRCGP

This week Richard discusses studies of glucose, insulin, and potassium for MI, elective PCI with and without surgical standby, and varenicline and CV risk.

---

May 4th, 2012

Reanalyzed Chantix Data Yield Smaller CV Risk, New Controversy

Physician's First Watch, CardioExchange Staff

A new meta-analysis criticizes earlier work warning that the smoking-cessation drug varenicline (Chantix) poses increased cardiovascular risks. The analysis appears in BMJ. It was performed by researchers with no current ties to the drug maker, but one of whom had received a Pfizer investigator-initiated research award. The new analysis examined the risk of treatment-emergent serious cardiovascular events […]

---

April 2nd, 2012

Selections from Richard Lehman’s Literature Review: Week of April 2nd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include cardiovascular risk among U.S. adults and statin-treated patients, mobility in those with type-2 diabetes, the causal association between IL6R-related pathways and CVD, and promoting exercise.

---

March 16th, 2012

Helping Patients Understand the Statins Controversy

Harlan M. Krumholz, MD, SM

After the Topol op-ed in the New York Times last week I began to get a lot of inquiries about the safety of statins. At the beginning of his piece he emphasizes that our use of statins could cause a “sharp increase in the incidence of Type 2 diabetes.” At the end, he states emphatically that “the […]

---